Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle

Cell therapy is increasingly recognized as a beneficial practice in various cardiac conditions, but its fundamentals remain largely unclear. The fates of transplanted multipotent stromal cells in postinfarction cardiac microenvironments are particularly understudied. To address this issue, labeled m...

Full description

Saved in:
Bibliographic Details
Main Authors: Timur Fatkhudinov, Galina Bolshakova, Irina Arutyunyan, Andrey Elchaninov, Andrey Makarov, Evgeniya Kananykhina, Oksana Khokhlova, Arkady Murashev, Valeria Glinkina, Dmitry Goldshtein, Gennady Sukhikh
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2015/746873
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691426199175168
author Timur Fatkhudinov
Galina Bolshakova
Irina Arutyunyan
Andrey Elchaninov
Andrey Makarov
Evgeniya Kananykhina
Oksana Khokhlova
Arkady Murashev
Valeria Glinkina
Dmitry Goldshtein
Gennady Sukhikh
author_facet Timur Fatkhudinov
Galina Bolshakova
Irina Arutyunyan
Andrey Elchaninov
Andrey Makarov
Evgeniya Kananykhina
Oksana Khokhlova
Arkady Murashev
Valeria Glinkina
Dmitry Goldshtein
Gennady Sukhikh
author_sort Timur Fatkhudinov
collection DOAJ
description Cell therapy is increasingly recognized as a beneficial practice in various cardiac conditions, but its fundamentals remain largely unclear. The fates of transplanted multipotent stromal cells in postinfarction cardiac microenvironments are particularly understudied. To address this issue, labeled multipotent stromal cells were infused into rat myocardium at day 30 after myocardial infarction, against the background of postinfarction cardiosclerosis. Therapeutic effects of the transplantation were assessed by an exercise tolerance test. Histological examination at 14 or 30 days after the transplantation was conducted by means of immunostaining and quantitative image analysis. An improvement in the functional status of the cardiovascular system was observed after both the autologous and the allogeneic transplantations. Location of the label-positive cells within the heart was restricted to the affected part of myocardium. The transplanted cells could give rise to fibroblasts or myofibroblasts but not to cardiac myocytes or blood vessel cells. Both types of transplantation positively influenced scarring processes, and no expansion of fibrosis to border myocardium was observed. Left ventricular wall thickening associated with reduced dilatation index was promoted by transplantation of the autologous cells. According to the results, multipotent stromal cell transplantation prevents adverse remodeling and stimulates left ventricular reverse remodeling.
format Article
id doaj-art-e7b90c42e1714b60a47317463d7d79eb
institution DOAJ
issn 1687-966X
1687-9678
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-e7b90c42e1714b60a47317463d7d79eb2025-08-20T03:21:02ZengWileyStem Cells International1687-966X1687-96782015-01-01201510.1155/2015/746873746873Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left VentricleTimur Fatkhudinov0Galina Bolshakova1Irina Arutyunyan2Andrey Elchaninov3Andrey Makarov4Evgeniya Kananykhina5Oksana Khokhlova6Arkady Murashev7Valeria Glinkina8Dmitry Goldshtein9Gennady Sukhikh10Research Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaResearch Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaResearch Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaResearch Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaResearch Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaResearch Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaBiological Testing Laboratory, Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 6 Nauki Avenue, Pushchino 142290, RussiaBiological Testing Laboratory, Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 6 Nauki Avenue, Pushchino 142290, RussiaPirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation, 1 Ostrovitianov Street, Moscow 117997, RussiaResearch Centre of Medical Genetics of the Russian Academy of Medical Sciences, 1 Moskvorechie Street, Moscow 115478, RussiaResearch Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, RussiaCell therapy is increasingly recognized as a beneficial practice in various cardiac conditions, but its fundamentals remain largely unclear. The fates of transplanted multipotent stromal cells in postinfarction cardiac microenvironments are particularly understudied. To address this issue, labeled multipotent stromal cells were infused into rat myocardium at day 30 after myocardial infarction, against the background of postinfarction cardiosclerosis. Therapeutic effects of the transplantation were assessed by an exercise tolerance test. Histological examination at 14 or 30 days after the transplantation was conducted by means of immunostaining and quantitative image analysis. An improvement in the functional status of the cardiovascular system was observed after both the autologous and the allogeneic transplantations. Location of the label-positive cells within the heart was restricted to the affected part of myocardium. The transplanted cells could give rise to fibroblasts or myofibroblasts but not to cardiac myocytes or blood vessel cells. Both types of transplantation positively influenced scarring processes, and no expansion of fibrosis to border myocardium was observed. Left ventricular wall thickening associated with reduced dilatation index was promoted by transplantation of the autologous cells. According to the results, multipotent stromal cell transplantation prevents adverse remodeling and stimulates left ventricular reverse remodeling.http://dx.doi.org/10.1155/2015/746873
spellingShingle Timur Fatkhudinov
Galina Bolshakova
Irina Arutyunyan
Andrey Elchaninov
Andrey Makarov
Evgeniya Kananykhina
Oksana Khokhlova
Arkady Murashev
Valeria Glinkina
Dmitry Goldshtein
Gennady Sukhikh
Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
Stem Cells International
title Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
title_full Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
title_fullStr Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
title_full_unstemmed Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
title_short Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle
title_sort bone marrow derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle
url http://dx.doi.org/10.1155/2015/746873
work_keys_str_mv AT timurfatkhudinov bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT galinabolshakova bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT irinaarutyunyan bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT andreyelchaninov bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT andreymakarov bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT evgeniyakananykhina bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT oksanakhokhlova bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT arkadymurashev bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT valeriaglinkina bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT dmitrygoldshtein bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle
AT gennadysukhikh bonemarrowderivedmultipotentstromalcellspromotemyocardialfibrosisandreverseremodelingoftheleftventricle